CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation - Sorbonne Université Access content directly
Conference Papers Year : 2017

CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation

No file

Dates and versions

hal-03969914 , version 1 (02-02-2023)

Identifiers

  • HAL Id : hal-03969914 , version 1

Cite

Jerome Caron, Veronique Pene, Maxime Villaret, Alexis Moravic, Eleanor Luce, et al.. CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation. 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Oct 2017, Washington, United States. ⟨hal-03969914⟩
36 View
0 Download

Share

Gmail Facebook X LinkedIn More